|
|
Volumn 15, Issue 9, 1997, Pages 829-
|
|
Phase II results in rheumatoid arthritis encouraging for immunex
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ETANERCEPT;
HYBRID PROTEIN;
IMMUNOGLOBULIN FC FRAGMENT;
MONOCLONAL ANTIBODY;
RECOMBINANT PROTEIN;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
DRUG ACTIVITY;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SCREENING;
HUMAN;
IMMUNOTHERAPY;
NOTE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
|
|
EID: 0030842623
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0997-829a Document Type: Letter |
|
Times cited : (1)
|
|
References (0)
|